e-Therapeutics uses a revolutionary computer-based platform and expertise in network biology to create completely new treatments for complex disease. 

GAINs picture.png
Our commercial business is growing and we are innovating our varied and convergent technologies.

In addition to internal discovery programmes we have existing partnerships with Novo Nordisk and a US-based top-five biopharmacetuical company and we are expecting the number of collaborations to grow. We are looking for talented scientists to join our team. Please get in touch at contact@etherapeutics.co.uk if you are interested.

Click on the job titles below for more information on our current vacancies:


Job Title: Senior/Principal Scientist

Location: Long Hanborough, Oxfordshire, UK

Salary/Package: £competitive, pension scheme contributions, discretionary bonus, BUPA private health insurance, 25 days holiday in addition to UK bank holidays

The role: You'll be working with our unique cutting-edge network biology and AI-driven drug discovery platform to uncover novel biology, therapeutic targets and small molecule drugs to address a range of diseases. As a member of our project teams you will be focused on addressing complex biological questions to tackle areas of unmet medical need and taking a lead role delivering exciting internal and collaborative discovery programmes, as well as assisting in the ongoing development of new capabilities.

The person: We're seeking an experienced cellular/molecular biologist with a track record in target identification and drug discovery. You'll have demonstrated creativity in your approach, while using the latest computational and data-driven approaches to gain insight in your work. You'll also be familiar with basic statistical concepts and approaches and keen to develop these skills. The ability and confidence to ask the right questions - both at a biological and project level - will be key to success in this role.

If you are interested in this role please send a CV and cover letter to contact@etherapeutics.co.uk

e-therapeutics has built a unique, network biology-based platform that facilitates a new approach to drug discovery, turning the traditional, target-based, "top down" approach on its head to address the challenges inherent in treating complex disease. The platform has been validated through the development of in-house assets in demanding areas such as immuno-oncology and neurodegeneration and our recent partnerships with Novo Nordisk and a top-five global biopharmaceutical company are the first in a series of collaborations exploring other new frontiers in medicine.

This focus on complex biology sets the company apart from others in the field, and for scientists excited by solving fascinating puzzles in high-impact disciplines, e-therapeutics provides unique challenges and opportunities for development.